Personalized Support for Progress (PSP) in a VA Women's Wellness Clinic

March 15, 2021 updated by: Emily M. Johnson, Syracuse VA Medical Center

Pilot Trial of Personalized Support for Progress (PSP) in a VA Women's Wellness Clinic

The purpose of this study is to evaluate the Personalized Support for Progress (PSP) intervention in a Veterans Health Administration (VHA) Women's Wellness Clinic. PSP uses a peer support provider to help women identify their primary concern, develop a personalized plan to help address that concern, and provide practical and emotional support to implement the plan. The primary aim is to evaluate the feasibility, acceptability, and utility of PSP and the research protocol.

Study Overview

Study Type

Interventional

Enrollment (Actual)

28

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New York
      • Syracuse, New York, United States, 13210
        • Syracuse VA Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Veteran status (non-Veterans will not be enrolled in this trial)
  • Enrollment in the Syracuse VA Medical Center Women's Wellness Clinic
  • Report high stress within the last month (Perceived Stress Scale [PSS-10] > 18)
  • Primary Care Provider approval for participation
  • Ability to communicate in English including reading, writing, hearing, and speaking well enough to complete research and intervention tasks.

Exclusion Criteria:

  • Any Veteran with "higher" suicide risk on the P4 or Veterans with "lower" suicide risk on the P4 and evaluated by the PI or another clinician to be clinically unstable or at risk
  • Homicidality (screened via adaptation of the P4 screener and evaluated on the same criteria above)
  • Homelessness (including literally homeless, imminent risk of homelessness, or fleeing/attempting to flee domestic violence per VA definitions)
  • Veterans who are enrolled in or have had psychotherapy or changes to psychotropic medications in the last 12 weeks
  • Veterans with impairment that would not allow them to engage in PSP including active psychosis, cognitive deficits, severe substance use requiring detoxification (documented in CPRS or reported by a PACT member)
  • Veterans who are not available for outpatient PSP meetings (e.g., in a residential program)
  • Veterans who have current VA or non-VA peer support engagement (an appointment within the last month and/or additional follow-up scheduled)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Treatment As Usual
Participants will receive treatment as usual within the VHA Women's Wellness Clinic including any appropriate treatment or treatments for their medical and psychosocial concerns as determined by their primary care teams.
Experimental: Treatment As Usual Plus Personalized Support for Progress
In addition to treatment as usual, women will receive the Personalized Support for Progress intervention.
Participants will receive the Personalized Support for Progress Intervention from a peer support provider including sessions with the peer support provider to complete a prioritization task, develop a personalized care plan, and receive support for implementing the personalized care plan.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assessment Retention Rate
Time Frame: 6 months
This is an assessment of trial feasibility.
6 months
Intervention Retention Rate
Time Frame: 6 months
This is an assessment of trial feasibility.
6 months
Client Satisfaction Questionnaire
Time Frame: 6 months
This scale measures satisfaction and ranges from 8-24 with higher scores indicating higher satisfaction.
6 months
Goal Attainment Scaling
Time Frame: 6 months
This interview assesses progress toward individualized goals on a -2 to 2 scale with higher scores indicating more progress toward goals.
6 months
Perceived Stress Scale (PSS-10)
Time Frame: 6 months
This scale evaluates perceived stress and ranges from 0-40 with lower scores indicating lower levels of perceived stress.
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 13, 2019

Primary Completion (Actual)

November 16, 2020

Study Completion (Actual)

March 3, 2021

Study Registration Dates

First Submitted

October 24, 2018

First Submitted That Met QC Criteria

April 5, 2019

First Posted (Actual)

April 9, 2019

Study Record Updates

Last Update Posted (Actual)

March 16, 2021

Last Update Submitted That Met QC Criteria

March 15, 2021

Last Verified

March 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 1297981

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Emotional Stress

Clinical Trials on Personalized Support for Progress

3
Subscribe